Greenwich Lifesciences, Inc.
SEC CIK 1799788 · GLSI · last insider filing 2026-01-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Patel Snehal | Director · CHIEF EXECUTIVE OFFICER | filed 2020 - 2026 |
| Mcwilliams David | Director | filed 2020 - 2024 |
| Daugherty Frank Joseph | Director · Chief Medical Officer | filed 2020 - 2024 |
| Rothe Eric | Director | filed 2020 - 2024 |
| Hallock Kenneth | Director | filed 2020 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thompson Jaye | VPC AND REGULATORY AFFAIRS | filed 2020 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.